Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.47 | -$0.38 | -$0.43 |
| Q2 2026 | 1 | -$0.47 | -$0.42 | -$0.45 |
| Q3 2026 | 1 | -$0.46 | -$0.41 | -$0.44 |
| Q4 2026 | 1 | -$0.38 | -$0.34 | -$0.37 |
| Q1 2027 | 1 | -$0.43 | -$0.38 | -$0.41 |
| Q2 2027 | 1 | -$0.43 | -$0.38 | -$0.41 |
| Q3 2027 | 1 | -$0.38 | -$0.34 | -$0.37 |
| Q4 2027 | 1 | -$0.39 | -$0.35 | -$0.38 |
Carlsmed Inc last posted its earnings results on Wednesday, February 25th, 2026. The company reported $-0.32 earnings per share for the quarter, topping analysts' consensus estimates of $-0.43 by $0.11. The company had revenue of 15.17 M for the quarter and had revenue of 50.51 M for the year. Carlsmed Inc has generated $-2 earnings per share over the last year ($-2.12 diluted earnings per share) and currently has a price-to-earnings ratio of -6.85. Carlsmed Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q4 2025 | -$0.43 | -$0.25 | 0.18 | $14.72 M | $15.17 M |
| 11/06/2025 | Q3 2025 | -$0.45 | -$0.40 | 0.05 | $11.24 M | $13.07 M |
| 08/28/2025 | Q2 2025 | -$1.52 | -$1.47 | 0.05 | $11.99 M | $12.08 M |
| 03/31/2025 | Q1 2025 | N/A | -$0.33 | N/A | N/A | $10.19 M |
| 12/31/2024 | Q4 2024 | N/A | -$0.18 | N/A | N/A | $9.41 M |
| 09/30/2024 | Q3 2024 | N/A | -$1.83 | N/A | N/A | $6.59 M |
| 06/30/2024 | Q2 2024 | N/A | -$1.55 | N/A | N/A | $6.08 M |
| 03/31/2024 | Q1 2024 | N/A | -$1.36 | N/A | N/A | $5.09 M |
| 12/30/2023 | Q4 2023 | N/A | -$0.21 | N/A | N/A | $4.34 M |
In the previous quarter, Carlsmed Inc (:CARL) reported $-0.32 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.43 by $0.11.
The conference call for Carlsmed Inc's latest earnings report can be listened to online.
The conference call transcript for Carlsmed Inc's latest earnings report can be read online.
Carlsmed Inc (:CARL) has a recorded annual revenue of $50.51 M.
Carlsmed Inc (:CARL) has a recorded net income of $-30,218,000.Carlsmed Inc has generated $-2.12 earnings per share over the last four quarters.
Carlsmed Inc (:CARL) has a price-to-earnings ratio of -6.85 and price/earnings-to-growth ratio is 2.33.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED